Trademark Overview
On Tuesday, November 7, 2023, a trademark application was filed for N NEXT & BIO with the United States Patent and Trademark Office. The USPTO has given the N NEXT & BIO trademark a serial number of 98259147. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Sunday, July 21, 2024. This trademark is owned by KOLMAR KOREA HOLDINGS CO., LTD.. The N NEXT & BIO trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Biological preparations for use in cell cultures for medical purposes, namely, for use in biotechnology for the treatment of cancer, infectious diseases, metabolic diseases and disorders; vaccines; reagents for medical use; medical diagnostic reagents; diagnostic preparations for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes; nutritional supplements; Veterinary preparations and substances for treating infections and inflammation; vitamin drops
Biological preparations for use in industry and science, other than for medical or veterinary purposes; cells for scientific or laboratory purposes; cultures of microorganisms for scientific or laboratory purposes, other than for medical and veterinary use; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; bacteria for use in food manufacture; probiotic bacterial cultures for use in the manufacture of food supplements in the food industry; diagnostic reagents, other than for medical or veterinary purposes; reagents for medical research; chemical preparations in the nature of chemical additives for use in the manufacture of pharmaceuticals
Medical analysis services for the diagnosis of cancer; medical services, namely, analysis of human tissues for medical treatment; medical analysis for the diagnosis and treatment of persons; medical services, namely, analysis of human biodata for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; medical examination services; information services relating to medical products for treatment and medical purposes; medical information
Development of biologics; scientific research in the field of pharmacy; scientific research in the fields of medicine, health and pharmacology; scientific research and testing services in the nature of chemical screening analysis for drug discovery for scientific research purposes; Platform as a Service featuring computer software platforms for screening new pharmaceuticals and precision medicine; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; medical research laboratory services; Software as a service featuring software for analyzing data, database management, and accounting related to drug discovery; Platform as a Service featuring software for analyzing data, database management, and accounting in the fields of medicine, health and pharmacology
